Clinical

Dataset Information

0

Decision-making of ctDNA in Patients With mCRC After Failure of First-line Treatment Containing Cetuximab - a Single-center, Phase II Clinical Study


ABSTRACT: This study aimis at detecting the genomic changes of ctDNA in patients of RAS and BRAF wild-type mCRC, who failed after first line treatment containing cetuximab. According to the results of ctDNA detection, individualized second-line targeted therapy strategies were developed to explore the disease control rate and prognostic significance of ctDNA-guided treatment for metastatic colorectal cancer.

DISEASE(S): Metastatic Colorectal Cancer,Colorectal Neoplasms

PROVIDER: 2373278 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Similar Datasets

2021-12-23 | GSE163763 | GEO
2019-01-01 | GSE93203 | GEO
| S-EPMC8096692 | biostudies-literature
| PRJEB72492 | ENA
| S-EPMC9722808 | biostudies-literature
| PRJEB113702 | ENA
| S-EPMC9690698 | biostudies-literature
| PRJEB22076 | ENA
2022-09-22 | GSE213615 | GEO
| S-EPMC7488718 | biostudies-literature